Skip to main content

Closed

LGVN: Longeveron Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-49.9% / yr

Operating margin-1881.7%

ROIC-130.4%

Financially safe

Stretched

Debt / equity0.05×

Interest coverage0.0×

Current ratio3.88×

Longeveron Inc.

LGVNNASDAQ Capital Market·USD·Closed

Longeveron Inc.

LGVNNASDAQ·USD·Closed

$0.70

+3.88%

$0.70

+$0.03 (3.88%)

52W Range

18thpctl

Volume

2.07×avg

Mkt Cap

13.98MUSD

P/E

-0.6TTM

Div Yield

–ann

52W Range

18thpctl

Volume

2.07×avg

Market Cap

13.98MUSD

P/E Ratio

-0.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings